Stephen Epstein
11Patents
6h-index
18Co-inventors
63Inventor score
Filing activity: Nov 27, 1991 → Apr 5, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5756476A | Inhibition of cell proliferation using antisense oligonucleotides | Chemistry; Metallurgy | 678 | Expired |
| US6835193B2 | Methods for controlled depth injections into interior body cavities | Human Necessities | 101 | Expired |
| US6595979B1 | Methods for sterile aspiration/reinjection of bodily fluid | Emerging Cross-Sectional Technologies | 97 | Expired |
| US5244460A | Method to foster myocardial blood vessel growth and improve blood flow to the heart | Human Necessities | 81 | Expired |
| US7097832B1 | Intramyocardial injection of autologous bone marrow | Human Necessities | 13 | Expired |
| US8911963B2 | Conditioned medium obtained from stem cells and its use in therapy | Human Necessities | 6 | Active |
| US6183752A | Restenosis/atherosclerosis diagnosis, prophylaxis and therapy | Chemistry; Metallurgy | 5 | Expired |
| US6682728B1 | Efficient and selective adenoviral-mediated gene transfer into vascular neointima | Chemistry; Metallurgy | 3 | Expired |
| US8853378B2 | Polynucleotides that home to atherosclerotic plaque | Chemistry; Metallurgy | 1 | Active |
| US8420590B2 | Genes and proteins that home to developing microvessels | Chemistry; Metallurgy | 0 | Active |
| US7527932B2 | Method of using physiological markers to estimate cardiovascular risk | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.